Sitagliptin anti-atherosclerotic effects may be inconsequential

Results of the PROLOGUE study show that the dipeptidyl peptidase-4 inhibitor sitagliptin has no greater effect than other antidiabetic medications on progression of carotid intima-media thickness.

Source: MedWire News - June 30, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news